Skip to content

Maya Armstrong

3 papers in the library · 19 citations · publishing 2022-2026

Papers

Sort Most recent Most cited

Community engagement as a foundation for implementation research for group psilocybin assisted therapy in New Mexico

Frontiers in Public Health June 17, 2026 Lawrence Leeman, Maya Armstrong, Dara Menashi et al.

Informed by a community engagement process, we have developed a pragmatic, open-label, hybrid feasibility-implementation study of Group Psilocybin-Assisted Therapy (GPAT) for post-traumatic stress disorder (PTSD). As psychedelic-assisted therapies begin to enter the broader mental health arena, engaging communities in the design of research and care models is essential to ensuring that those...

Chronic pain as an emergent property of a complex system and the potential roles of psychedelic therapies.

Front Pain Res (Lausanne) April 19, 2024 Maya Armstrong, Joel Castellanos, Devon Christie 15 citations

Despite research advances and urgent calls by national and global health organizations, clinical outcomes for millions of people suffering with chronic pain remain poor. We suggest bringing the lens of complexity science to this problem, conceptualizing chronic pain as an emergent property of a complex biopsychosocial system. We frame pain-related physiology, neuroscience, developmental...

Psychedelic Therapies at the Crossroads of Trauma and Substance Use: Historical Perspectives and Future Directions, Taking a Lead From New Mexico

Frontiers in Pharmacology June 27, 2022 Snehal Bhatt, Maya Armstrong, Tassy Parker et al. 4 citations

Post-traumatic stress disorder (PTSD), a common condition with potentially devastating individual, family, and societal consequences, is highly associated with substance use disorders (SUDs). The association between PTSD and SUD is complex and may involve adverse childhood experiences (ACEs), historical and multi-generational traumas, and social determinants of health as well as cultural and...